Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Oral ulcers are common in SLE patients and often link to other symptoms.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Shift nurses show altered body temperature and stress hormone levels, suggesting their body clocks adjust to irregular schedules.

The A allele of the C2 gene increases the risk of lupus, while the G allele may protect against it.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

A 13-year-old girl was diagnosed with juvenile lupus, showing only hair loss as a symptom.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Iron deficiency might contribute to hair loss in women.

Certain gene variations may increase the risk and severity of alopecia areata.

Histone modification is key in treating chronic inflammatory skin diseases.

SLE significantly affects daily life, especially through fatigue and joint pain, highlighting the need for better treatments.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.